- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04422691
Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection (COVIDUS-NOR)
Bruk av Ultralyd i Evaluering av Pasienter Med Mistenkt COVID-19 Infeksjon i Norge
In light of the ongoing COVID-19 epidemic in Norway, it is paramount to develop and utilize clinical tools for assessing and risk stratifying patients with suspected coronary infection in the emergency departments. Diagnostic use of ultrasound in viral pneumonias, including COVID-19 has proved to be very useful. The use of ultrasound will assist in quick detection of lung pathology compatible with increasing severity of the COVID-19 disease. At the same time, the use of ultrasound diagnostics in the emergency department could improve logistics and reduce potential exposure of the corona virus to other health personnel.
The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bergen, Norway
- Haukeland Universitetssykehus
-
Bodø, Norway
- Nordland Hospital
-
Drammen, Norway
- Drammen sykehus
-
Kristiansand, Norway
- Sørlandet sykehus, Kristiansand
-
Oslo, Norway
- Akershus University Hospital
-
Oslo, Norway
- Ullevål University Hospital
-
Skien, Norway
- Sykehuset Telemark HF
-
Stavanger, Norway
- Stavanger Universitetssjukehus
-
Trondheim, Norway
- St Olavs Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All emergency department patients with suspected or diagnosed COVID-19.
Exclusion Criteria:
- Negative screening for COVID-19
- recent negative COVID-19 test
- no indication for isolation in the Emergency Department
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Covid-19 suspected
Emergency department patients with suspected or diagnosed COVID-19 disease.
All patients will be screened at triage and put into isolation if suspected disease.
Ultrasound of the patients lungs will be performed after patient consent and findings will be recorded and categorized (Soldati et al., 2020).
The use of ultrasound and registration of data will not affect the regular patient evaluation, treatment or logistics.
|
After verbal consent the enrolled patients' lungs are evaluated with ultrasound while in isolation.
The lungs are divided into 3 fields and findings are categorized according to Soldati et al., 2020.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: up to 30 days
|
30-day mortality
|
up to 30 days
|
Level-of-care
Time Frame: up to 7 days
|
In-hospital treatment level, e.g.
discharge from ED, observational unit, ward, ICU.
|
up to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
In-hospital length of stay
Time Frame: Up to 30 days
|
in days
|
Up to 30 days
|
Oxygen usage in the emergency department
Time Frame: Within 24 hours
|
Within 24 hours
|
|
Emergency department length of stay
Time Frame: Within 24 hours
|
in hours
|
Within 24 hours
|
Antibiotics usage
Time Frame: Within 24 hours
|
Within 24 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical correlation
Time Frame: Within 3 days
|
Clinical correlation between ultrasound findings and vital signs, labs, blood gas and other diagnostic modalities.
|
Within 3 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars Petter Bjørnsen, MD, PhD, NTNU/St. Olav's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REK129805
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Massachusetts General HospitalRecruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityShangluo Central Hospital; Ankang Central Hospital; Hanzhong Central Hospital; Yulin... and other collaboratorsRecruitingCOVID-19 | Post-COVID-19 Syndrome | Post-Acute COVID-19 | Acute COVID-19China
Clinical Trials on Lung ultrasound
-
Kasr El Aini HospitalCompletedExta Vascular Lung WaterEgypt
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States
-
Assiut UniversityCompleted
-
University of MilanCompletedLung Cancer | Community Acquired Pneumonia | Pulmonary Embolism | PleuritisItaly
-
Groupe Hospitalier Paris Saint JosephHopital ForcillesActive, not recruitingCOVID-19 | Weaning Failure | ICU Acquired WeaknessFrance
-
Xiangtan Central HospitalActive, not recruitingHeart Failure | Lung UltrasoundChina
-
Cliniques universitaires Saint-Luc- Université...RecruitingInterstitial Lung DiseaseBelgium
-
Phoenix Children's HospitalChildren's Hospital Los Angeles; Baylor Scott and White Health; St. Joseph's... and other collaboratorsEnrolling by invitationBronchopulmonary DysplasiaUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Hospital Vall d'Hebron; Institut Hospital del Mar d'Investigacions MédiquesCompletedHeart Failure | Acute Myocardial InfarctionSpain
-
Centre Hospitalier Universitaire, AmiensCentre Hospitalier de Beauvais; Centre Hospitalier de Clermont; Centre Hospitalier... and other collaboratorsCompleted